FR2207712A1 - - Google Patents

Info

Publication number
FR2207712A1
FR2207712A1 FR7341450A FR7341450A FR2207712A1 FR 2207712 A1 FR2207712 A1 FR 2207712A1 FR 7341450 A FR7341450 A FR 7341450A FR 7341450 A FR7341450 A FR 7341450A FR 2207712 A1 FR2207712 A1 FR 2207712A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7341450A
Other languages
French (fr)
Other versions
FR2207712B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MSD International Holdings GmbH
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherico Ltd filed Critical Scherico Ltd
Publication of FR2207712A1 publication Critical patent/FR2207712A1/fr
Application granted granted Critical
Publication of FR2207712B1 publication Critical patent/FR2207712B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7341450A 1972-11-24 1973-11-21 Expired FR2207712B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30953972A 1972-11-24 1972-11-24
US371452A US3875229A (en) 1972-11-24 1973-06-19 Substituted carboxanilides

Publications (2)

Publication Number Publication Date
FR2207712A1 true FR2207712A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-06-21
FR2207712B1 FR2207712B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1976-12-03

Family

ID=26976880

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7341450A Expired FR2207712B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1972-11-24 1973-11-21

Country Status (12)

Country Link
US (1) US3875229A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS4981332A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG (1) BG21392A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (1) DD110856A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2357757A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES420688A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2207712B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1446084A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU169277B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE38530B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL43664A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL7315903A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4230483A (en) * 1977-06-21 1980-10-28 Stauffer Chemical Company Substituted cyclopropylmethoxy phenyl carbamates and thiocarbamates and their use as herbicides
US4356026A (en) * 1977-06-21 1982-10-26 Stauffer Chemical Company Substituted cyclopropylmethoxy phenyl ureas and their use as herbicides
US4149874A (en) * 1977-06-21 1979-04-17 Stauffer Chemical Company Substituted cyclopropylmethoxy anilides and their use as herbicides
EP0002309B1 (en) * 1977-10-12 1982-12-01 Imperial Chemical Industries Plc Acylanilides, process for their manufacture and pharmaceutical and veterinary compositions containing them
US4191775A (en) * 1977-12-15 1980-03-04 Imperial Chemical Industries Limited Amide derivatives
DK529378A (da) * 1978-01-09 1979-07-10 Shell Int Research Anilidderivater
EP0100172B1 (en) * 1982-07-23 1987-08-12 Imperial Chemical Industries Plc Amide derivatives
GB8617652D0 (en) * 1986-07-18 1986-08-28 Ici Plc Acylanilide derivatives
US4921941A (en) * 1987-07-01 1990-05-01 Schering Corporation Orally active antiandrogens
US4895715A (en) * 1988-04-14 1990-01-23 Schering Corporation Method of treating gynecomastia
WO1998022432A1 (fr) * 1996-11-18 1998-05-28 Yamanouchi Pharmaceutical Co., Ltd. Derives d'acylanilide a substitution acylamino ou composition comprenant ces derives
US6071957A (en) * 1996-11-27 2000-06-06 The University Of Tennessee Research Corporation Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer
US20050038110A1 (en) * 2000-08-24 2005-02-17 Steiner Mitchell S. Selective androgen receptor modulators and methods of use thereof
US7759520B2 (en) * 1996-11-27 2010-07-20 University Of Tennessee Research Foundation Synthesis of selective androgen receptor modulators
US7518013B2 (en) * 2000-08-24 2009-04-14 University Of Tennessee Research Foundation Selective androgen receptor modulators
US6492554B2 (en) 2000-08-24 2002-12-10 The University Of Tennessee Research Corporation Selective androgen receptor modulators and methods of use thereof
US6995284B2 (en) * 2000-08-24 2006-02-07 The University Of Tennessee Research Foundation Synthesis of selective androgen receptor modulators
WO1998053826A1 (en) * 1997-05-30 1998-12-03 The University Of Tennessee Research Corporation Non-steroidal agonist compounds and their use in male hormone therapy
AU7723198A (en) * 1997-06-04 1998-12-21 University Of Tennessee Research Corporation, The Non-steroidal radiolabeled agonist/antagonist compounds and their use in prostate cancer imaging
US20040186185A1 (en) * 1998-05-07 2004-09-23 Steiner Mitchell S. Method for treatment and chemoprevention of prostate cancer
US7026500B2 (en) * 2000-08-24 2006-04-11 University Of Tennessee Research Foundation Halogenated selective androgen receptor modulators and methods of use thereof
US7645898B2 (en) * 2000-08-24 2010-01-12 University Of Tennessee Research Foundation Selective androgen receptor modulators and method of use thereof
US7919647B2 (en) * 2000-08-24 2011-04-05 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
US20040260108A1 (en) * 2001-06-25 2004-12-23 Dalton James T. Metabolites of selective androgen receptor modulators and methods of use thereof
US8008348B2 (en) * 2001-12-06 2011-08-30 University Of Tennessee Research Foundation Treating muscle wasting with selective androgen receptor modulators
US8445534B2 (en) * 2000-08-24 2013-05-21 University Of Tennessee Research Foundation Treating androgen decline in aging male (ADAM)-associated conditions with SARMs
US20070173546A1 (en) * 2000-08-24 2007-07-26 Dalton James T Selective androgen receptor modulators and method of use thereof
US7622503B2 (en) * 2000-08-24 2009-11-24 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
SI1401801T1 (sl) 2000-08-24 2007-04-30 Univ Tennessee Res Foundation Selektivni modulatorji androgenskega receptorja in postopki za njihovo uporabo
US7855229B2 (en) * 2000-08-24 2010-12-21 University Of Tennessee Research Foundation Treating wasting disorders with selective androgen receptor modulators
US6998500B2 (en) * 2000-08-24 2006-02-14 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
US6838484B2 (en) * 2000-08-24 2005-01-04 University Of Tennessee Research Foundation Formulations comprising selective androgen receptor modulators
US7102026B2 (en) * 2001-06-13 2006-09-05 Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság Process for preparing and isolating rac-bicalutamide and its intermediates
US20060287282A1 (en) * 2001-06-25 2006-12-21 Steiner Mitchell S Compositions comprising a SARM ad GnRH agonist or a GnRH antagonist, and methods of use thereof
US7015253B2 (en) * 2001-07-10 2006-03-21 American Medical Systems, Inc. Regimen for treating prostate tissue and surgical kit for use in the regimen
US8853266B2 (en) * 2001-12-06 2014-10-07 University Of Tennessee Research Foundation Selective androgen receptor modulators for treating diabetes
US20070161608A1 (en) * 2001-12-06 2007-07-12 Dalton James T Selective androgen receptor modulators for treating muscle wasting
CA2469340A1 (en) * 2001-12-06 2003-06-19 Gtx Inc. Treating muscle wasting with selective androgen receptor modulators
US7595402B2 (en) * 2003-12-16 2009-09-29 Gtx, Inc. Prodrugs of selective androgen receptor modulators and methods of use thereof
CA2475108A1 (en) * 2002-02-07 2003-08-14 Mitchell S. Steiner Treating benign prostate hyperplasia with sarms
US7803970B2 (en) * 2002-02-28 2010-09-28 University Of Tennessee Research Foundation Multi-substitued selective androgen receptor modulators and methods of use thereof
KR101088352B1 (ko) * 2002-02-28 2011-11-30 유니버시티 오브 테네시 리서치 파운데이션 다치환된 선택적 안드로겐 수용체 조절자 및 이를 사용하는 방법
US7344700B2 (en) * 2002-02-28 2008-03-18 University Of Tennessee Research Corporation Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy
WO2003074471A1 (en) * 2002-02-28 2003-09-12 University Of Tennessee Research Foundation Haloacetamide and azide substituted compounds and methods of use thereof
US7772433B2 (en) * 2002-02-28 2010-08-10 University Of Tennessee Research Foundation SARMS and method of use thereof
US7741371B2 (en) * 2002-06-17 2010-06-22 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
CA2489182A1 (en) * 2002-06-17 2003-12-24 University Of Tennessee Research Foundation N-bridged selective androgen receptor modulators and methods of use thereof
AU2003248052A1 (en) * 2002-07-12 2004-02-02 Yamanouchi Pharmaceutical Co., Ltd. N-phenyl-(2r,5s)dimethylpiperadine derivative
CA2502209A1 (en) * 2002-10-15 2004-04-29 University Of Tennessee Research Foundation Methylene-bridged selective androgen receptor modulators and methods of use thereof
US20040197928A1 (en) * 2002-10-15 2004-10-07 Dalton James T. Method for detecting selective androgen receptor modulators
CA2501797A1 (en) * 2002-10-15 2004-04-29 Gtx, Inc. Treating obesity with selective androgen receptor modulators
AU2003287079A1 (en) * 2002-10-16 2004-05-04 Gtx, Inc. Treating androgen decline in aging male (adam)-associated conditions with sarms
US20060276539A1 (en) * 2002-10-16 2006-12-07 Dalton James T Treating Androgen Decline in Aging Male (ADAM)- associated conditions with SARMS
US20040087810A1 (en) * 2002-10-23 2004-05-06 Dalton James T. Irreversible selective androgen receptor modulators and methods of use thereof
US8309603B2 (en) * 2004-06-07 2012-11-13 University Of Tennessee Research Foundation SARMs and method of use thereof
US20040167103A1 (en) * 2003-02-24 2004-08-26 Dalton James T. Haloacetamide and azide substituted compounds and methods of use thereof
US9884038B2 (en) 2004-06-07 2018-02-06 University Of Tennessee Research Foundation Selective androgen receptor modulator and methods of use thereof
US9889110B2 (en) 2004-06-07 2018-02-13 University Of Tennessee Research Foundation Selective androgen receptor modulator for treating hormone-related conditions
US20110237664A1 (en) * 2004-06-07 2011-09-29 Dalton James T Selective androgen receptor modulators for treating diabetes
US20060258628A1 (en) * 2004-07-20 2006-11-16 Steiner Mitchell S Compositions comprising 5-alpha reductase inhibitors, and SARMs and methods of use thereof
US9730908B2 (en) 2006-08-24 2017-08-15 University Of Tennessee Research Foundation SARMs and method of use thereof
CN101528214B (zh) 2006-08-24 2013-06-05 田纳西大学研究基金会 取代的n-酰基苯胺及其使用方法
US9844528B2 (en) 2006-08-24 2017-12-19 University Of Tennessee Research Foundation SARMs and method of use thereof
US10010521B2 (en) 2006-08-24 2018-07-03 University Of Tennessee Research Foundation SARMs and method of use thereof
JP5369336B2 (ja) * 2007-01-02 2013-12-18 アクアビーム エルエルシー 前立腺の疾患を治療するための侵襲性が最小である方法及びデバイス
US9232959B2 (en) 2007-01-02 2016-01-12 Aquabeam, Llc Multi fluid tissue resection methods and devices
US12290277B2 (en) 2007-01-02 2025-05-06 Aquabeam, Llc Tissue resection with pressure sensing
US20080245375A1 (en) * 2007-04-05 2008-10-09 Medtronic Vascular, Inc. Benign Prostatic Hyperplasia Treatments
WO2008137038A1 (en) * 2007-05-03 2008-11-13 Yale University Locally active 'soft' antiandrogens
US7968603B2 (en) 2007-09-11 2011-06-28 University Of Tennessee Research Foundation Solid forms of selective androgen receptor modulators
EP2259742B1 (en) * 2008-03-06 2020-01-01 AquaBeam LLC Tissue ablation and cautery with optical energy carried in fluid stream
US9848904B2 (en) 2009-03-06 2017-12-26 Procept Biorobotics Corporation Tissue resection and treatment with shedding pulses
WO2014127242A2 (en) 2013-02-14 2014-08-21 Procept Biorobotics Corporation Aquablation aquabeam eye surgery methods and apparatus
WO2016037137A1 (en) 2014-09-05 2016-03-10 Procept Biorobotics Corporation Physician controlled tissue resection integrated with treatment mapping of target organ images
WO2012109387A1 (en) 2011-02-08 2012-08-16 Halozyme, Inc. Composition and lipid formulation of a hyaluronan-degrading enzyme and the use thereof for treatment of benign prostatic hyperplasia
JP6080872B2 (ja) 2012-02-29 2017-02-15 プロセプト バイオロボティクス コーポレイション 自動化された画像誘導組織切除および治療
CN110840870A (zh) 2012-07-13 2020-02-28 Gtx公司 选择性雄激素受体调节剂在治疗转移性和难治性乳癌中的应用
US10987334B2 (en) 2012-07-13 2021-04-27 University Of Tennessee Research Foundation Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs)
US9622992B2 (en) 2012-07-13 2017-04-18 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US9744149B2 (en) 2012-07-13 2017-08-29 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US10258596B2 (en) 2012-07-13 2019-04-16 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
US10314807B2 (en) 2012-07-13 2019-06-11 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
US9969683B2 (en) 2012-07-13 2018-05-15 Gtx, Inc. Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS)
CN105764436B (zh) 2013-09-06 2019-04-26 普罗赛普特生物机器人公司 利用致脱脉冲的用于消融组织的装置
CN106572864B (zh) 2014-06-30 2020-06-09 普罗赛普特生物机器人公司 流体射流组织切除和寒凝装置

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1268684A (fr) * 1960-08-08 1961-08-04 Basf Ag Procédé pour la production d'amides d'acide beta-hydroxypropionique nu-substituéset de leurs esters avec des acides forts, oxygénés
DE1173082B (de) * 1962-06-06 1964-07-02 Bayer Ag Verfahren zur Herstellung von N-mono-substituierten ª‡-Hydroxycarbonsaeureamiden

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3197503A (en) * 1962-12-14 1965-07-27 Monsanto Co N-(aryl) oxamic acid chlorides
US3201466A (en) * 1963-03-08 1965-08-17 Gulf Oil Corp Substituted cyclopropanecarboxanilide herbicides
NL123536C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1963-07-09
DE1189312B (de) * 1963-12-06 1965-03-18 Schering Ag Mittel mit selektiver herbizider Wirkung
GB1065801A (en) * 1964-02-19 1967-04-19 Nippon Soda Co N-substituted fluoroacetamides and their use as insecticides
US3418345A (en) * 1965-10-18 1968-12-24 Monsanto Co Halonitroanilides
US3426049A (en) * 1965-10-18 1969-02-04 Monsanto Co Nitrotrifluoromethylanilides
US3462486A (en) * 1966-12-28 1969-08-19 Gulf Oil Corp Method for preparing 3',4'-dichloro-cyclopropanecarboxanilide
US3608087A (en) * 1968-06-21 1971-09-21 Merck & Co Inc Feed compositions
US3723442A (en) * 1970-12-31 1973-03-27 Yoshitomi Pharmaceutical 3-oxo-1-oxa-4,8-diazaspiro(4.5)decanes
US3720686A (en) * 1971-04-01 1973-03-13 Squibb & Sons Inc Mercaptobenzimidazole derivatives

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1268684A (fr) * 1960-08-08 1961-08-04 Basf Ag Procédé pour la production d'amides d'acide beta-hydroxypropionique nu-substituéset de leurs esters avec des acides forts, oxygénés
DE1173082B (de) * 1962-06-06 1964-07-02 Bayer Ag Verfahren zur Herstellung von N-mono-substituierten ª‡-Hydroxycarbonsaeureamiden

Also Published As

Publication number Publication date
BG21392A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1976-05-20
IL43664A0 (en) 1974-03-14
IE38530L (en) 1974-05-24
AU6270573A (en) 1975-05-22
DD110856A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-01-12
JPS4981332A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-08-06
ES420688A1 (es) 1976-09-01
NL7315903A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-05-28
HU169277B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1976-10-28
FR2207712B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1976-12-03
DE2357757A1 (de) 1974-06-06
GB1446084A (en) 1976-08-11
IE38530B1 (en) 1978-03-29
US3875229A (en) 1975-04-01

Similar Documents

Publication Publication Date Title
FR2207712A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS5511623B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH545667A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH552237A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH554968A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH559842A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH560967A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH561450A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH562400A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH563846A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH564147A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH565891A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH565954A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH568421A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH568548A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH568625A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH568840A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH569028A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH569143A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH569152A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH569398A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH571873A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH571887A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH572544B5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH572640A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Legal Events

Date Code Title Description
ST Notification of lapse